1. Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic. (5th November 2018) Authors: Chan, T A; Yarchoan, M; Jaffee, E; Swanton, C; Quezada, S A; Stenzinger, A; Peters, S Journal: Annals of oncology Issue: Volume 30:Number 1(2019) Page Start: 44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗